Last $60.99 USD
Change Today -0.80 / -1.29%
Volume 114.8K
CYBX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 3:20 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

cyberonics inc (CYBX) Snapshot

Open
$60.67
Previous Close
$61.79
Day High
$61.67
Day Low
$60.57
52 Week High
02/14/14 - $73.52
52 Week Low
09/30/13 - $49.65
Market Cap
1.6B
Average Volume 10 Days
329.7K
EPS TTM
$2.17
Shares Outstanding
26.7M
EX-Date
--
P/E TM
28.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CYBERONICS INC (CYBX)

cyberonics inc (CYBX) Related Bloomberg News

View More Bloomberg News

cyberonics inc (CYBX) Related Businessweek News

No Related Businessweek News Found

cyberonics inc (CYBX) Details

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that uses pulsed electrical signals applied to the vagus nerve for the treatment of refractory epilepsy and treatment-resistant depression. It is also engaged in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.

639 Employees
Last Reported Date: 06/16/14
Founded in 1987

cyberonics inc (CYBX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $562.9K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.1K
Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $307.5K
Senior Vice President of Research & Developme...
Total Annual Compensation: $297.5K
Vice President of Emerging Therapies
Total Annual Compensation: $100.4K
Compensation as of Fiscal Year 2013.

cyberonics inc (CYBX) Key Developments

Cyberonics Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended April 25, 2014; Provides Earnings Guidance for the Fiscal Year 2015

Cyberonics Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended April 25, 2014. For the quarter, the company reported net sales of $74,849,270 compared with $68,343,567 for the same period last year. Income from operations was $23,418,020 compared with $20,463,569 for the same period last year. Interest income was $37,469 compared with $43,653 for the same period last year. Income before income taxes was $23,363,352 compared with $20,359,620 for the same period last year. Net income was $18,428,006 or $0.68 diluted per share compared with $11,532,071 or $0.41 diluted per share for the same period last year. Adjusted non-GAAP net income was $14,894,331 or $0.55 diluted per share compared with $12,871,632 or $0.46 diluted per share for the same period last year. Adjusted EBITDA was $27,718,303 compared with $24,234,751 for the same period last year. Adjusted non-GAAP income from operations was $23,418,020 against $20,463,569 a year ago. For the year, the company reported net sales of $282,014,160 compared with $254,320,417 for the same period last year. Income from operations was $80,011,750 compared with $78,346,447 for the same period last year. Interest income was $182,266 compared with $84,287 for the same period last year. Income before income taxes was $79,878,696 compared with $75,274,625 for the same period last year. Net income was $54,890,257 or $2.00 diluted per share compared with $46,357,502 or $1.66 diluted per share for the same period last year. Adjusted non-GAAP net income was $56,132,657 or $2.04 diluted per share compared with $48,844,090 or $1.74 diluted per share for the same period last year. Adjusted EBITDA was $104,297,077 compared with $94,668,065 for the same period last year. Adjusted non-GAAP income from operations was $87,454,597 against $78,346,447 a year ago. Net cash provided by operating activities was $54,195,816 against $78,954,186 a year ago. Purchases of property, plant and equipment was $15,222,440 against $9,705,446 a year ago. Intangible asset purchases was $3,839,000 against $4,600,000 a year ago. For the fiscal year 2015, net sales are expected to be in the range of $300 million to $307 million. Gross profit is expected to be between 90.0% and 91.0%. Income from operations is expected to be in the range of $96 million to $99 million. The company anticipates an effective tax rate of approximately 35% for fiscal 2015, which assumes the renewal of the R & D tax credit. Net income for fiscal 2015 is expected to be in the range of $62 million to $64 million. The company expects that diluted earnings per share (EPS) will be in the range of $2.33 to $2.39.

Cyberonics Inc. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-11-2014 12:40 PM

Cyberonics Inc. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-11-2014 12:40 PM. Venue: Four Seasons Hotel, 120 East Delaware Place, Chicago, Illinois, United States. Speakers: Gregory H. Browne, Chief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance.

Cyberonics Inc. to Report Q4, 2014 Results on Jun 04, 2014

Cyberonics Inc. announced that they will report Q4, 2014 results at 9:00 AM, Eastern Standard Time on Jun 04, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYBX:US $60.99 USD -0.80

CYBX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Exactech Inc $24.50 USD -0.40
ICU Medical Inc $60.38 USD -0.73
Thoratec Corp $33.51 USD -0.39
Tornier NV $22.88 USD -0.31
Wright Medical Group Inc $30.95 USD -0.36
View Industry Companies
 

Industry Analysis

CYBX

Industry Average

Valuation CYBX Industry Range
Price/Earnings 30.9x
Price/Sales 5.9x
Price/Book 6.4x
Price/Cash Flow 30.0x
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYBERONICS INC, please visit www.cyberonics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.